We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
MLEC | Moolec Science SA | 10.20 | 2.11 | 26.08% | 130,663 |
KIDZ | Classover Holdings Inc | 1.1987 | 0.2289 | 23.60% | 6,949,078 |
SANM | Sanmina Corporation | 212.00 | 23.92 | 12.72% | 211,116 |
BMEA | Biomea Fusion Inc | 1.94 | 0.21 | 12.14% | 613,060 |
RVMD | Revolution Medicines Inc | 143.60 | 11.93 | 9.06% | 113,937 |
MATH | Metalpha Technology Holding Ltd | 1.09 | 0.08 | 7.92% | 104 |
OCG | Oriental Culture Holdings Ltd | 2.13 | 0.15 | 7.58% | 1,470,687 |
OTEX | Open Text Corporation | 24.123 | 1.61 | 7.17% | 585 |
DAIC | CID HoldCo Inc | 0.2099 | 0.0137 | 6.98% | 1,290,422 |
DWTX | Dogwood Therapeutics Inc | 1.43 | 0.09 | 6.72% | 1,312 |
TDIC | Dreamland Ltd | 1.13 | 0.07 | 6.60% | 13,527 |
Board of Directors Authorize $600 Million Share Repurchase ProgramSAN JOSE, Calif., April 27, 2026 /PRNewswire/ -- Sanmina Corporation ("Sanmina" or the "Company") (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the second quarter ended March 28, 2026 and outlook for its third fiscal quarter ending June 27, 2026.
Rambus Inc. (NASDAQ:RMBS), a provider of industry-leading chips and IP making data faster and safer, today reported financial results for the first quarter ended March 31, 2026. GAAP revenue for the first quarter was $180.2 million, licensing billings were $70.8 million, product revenue was $88.0 million, and contract and other revenue was $22.6 million. The Company also generated $83.2 million in cash from operating activities in the first quarter.
TORONTO, April 24, 2026 /PRNewswire/ - Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM) is pleased to announce that further to its news release dated April 22, 2026, regarding the previously announced financing with Hartree Partners, LP ("Hartree"), a strategic partner to Blue Moon, the Company has issued 526,617 common shares to Hartree for total gross proceeds of approximately C$4.8 million (the "Financing").
Financing led by institutional life sciences investor, with participation from new and existing investorsCapital expected to support expansion of CDMO platform and advancement of customer programsJERUSALEM, April 24, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics and the owner of Scinai Biopharma Services Ltd., a contract development and manufacturing organization (CDMO), today announced that it has entered into a securities purchase agreement with an institutional life sciences investor, as well as with new and existing institutional and accredited investors, for the purchase and sale ...
| Rank | Ticker | Board Name | Posts (24h) |
|---|---|---|---|
| LWLG | Lightwave Logic Inc | ||
| ECOX | Eco Innovation Group Inc | ||
| HIRU | Hiru Corporation | ||
| 4 | BIEI | Premier Biomedical Inc | |
| 5 | RITE | MineralRite Corp | |
| 6 | BIEL | Bioelectronics Corp |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions